litlas
Log inCreate account

Edward M. Sellers

Active 1969–2023

101
Papers
29,687
Citations
85
h-index
101
i10-index

Citations

Citations per year for Edward M. Sellers1970: 1 citations1971: 6 citations1972: 6 citations1973: 2 citations1974: 8 citations1975: 12 citations1976: 15 citations1977: 22 citations1978: 11 citations1979: 16 citations1980: 22 citations1981: 14 citations1982: 26 citations1983: 42 citations1984: 23 citations1985: 26 citations1986: 32 citations1987: 34 citations1988: 51 citations1989: 67 citations1990: 51 citations1991: 58 citations1992: 51 citations1993: 41 citations1994: 80 citations1995: 80 citations1996: 104 citations1997: 120 citations1998: 85 citations1999: 126 citations2000: 150 citations2001: 149 citations2002: 177 citations2003: 177 citations2004: 175 citations2005: 196 citations2006: 196 citations2007: 202 citations2008: 145 citations2009: 162 citations2010: 113 citations2011: 157 citations2012: 118 citations2013: 96 citations2014: 111 citations2015: 99 citations2016: 79 citations2017: 101 citations2018: 68 citations2019: 290 citations2020: 316 citations2021: 268 citations2022: 192 citations2023: 104 citations2024: 223 citations2025: 83 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,304 citing papers, 39.9% of this breakdownCanada: 409 citing papers, 7.1% of this breakdownUnited Kingdom: 368 citing papers, 6.4% of this breakdownGermany: 246 citing papers, 4.3% of this breakdownItaly: 216 citing papers, 3.7% of this breakdownAustralia: 199 citing papers, 3.4% of this breakdownFrance: 188 citing papers, 3.3% of this breakdownChina: 159 citing papers, 2.7% of this breakdownNetherlands: 126 citing papers, 2.2% of this breakdownJapan: 117 citing papers, 2% of this breakdownSpain: 113 citing papers, 2% of this breakdownIndia: 111 citing papers, 1.9% of this breakdown
0%39.9%Other 21.1%

Institutions

Fields

  • Medicine54%
  • Pharmacology, Toxicology and Pharmaceutics14.9%
  • Neuroscience13.1%
  • Biochemistry, Genetics and Molecular Biology6.9%
  • Psychology5.3%
  • Health Professions1%
  • Other4.8%

Topics

  • Neurotransmitter Receptor Influence on Behavior5%
  • Pharmacogenetics and Drug Metabolism4.1%
  • Substance Abuse Treatment and Outcomes3.3%
  • Pharmacovigilance and Adverse Drug Reactions2.8%
  • Alcoholism and Thiamine Deficiency2.5%
  • Neuroscience and Neuropharmacology Research2%
  • Other80.3%

Coauthors

All papers

Open in search
  1. A method for estimating the probability of adverse drug reactions

    Authors: C. A. Naranjo, U. Busto, Edward M. Sellers, Paul Sandor, Inés Ruiz, E A Roberts, E Janecek, C Domecq, D J Greenblatt - Clinical Pharmacology & Therapeutics 1981 cited by 11,628

  2. Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar)

    Authors: John T. Sullivan, Kathy Sykora, Joyce Schneiderman, Claudio A. Naranjo, Edward M. Sellers - British Journal of Addiction 1989 cited by 1,979

  3. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

    Authors: Kerri A. Schoedel, Isabella Szeto, Beatrice Setnik, Edward M. Sellers, Naama Levy‐Cooperman, Catherine Mills, Tilden Etges, Kenneth W. Sommerville - Epilepsy & Behavior 2018 cited by 166

  4. Cortical γ-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder

    Authors: C. Neill Epperson, Kristin Haga, Graeme F. Mason, Edward M. Sellers, Ralitza Gueorguieva, Wenjiang Zhang, Erica L. Weiss, Douglas L. Rothman, John H. Krystal - Archives of General Psychiatry 2002 cited by 406

  5. Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

    Authors: Guy A. Higgins, Nicole K. Carroll, Matthew A. Brown, Cam MacMillan, Leo B. Silenieks, Sandy Thevarkunnel, Julia Izhakova, Lilia Magomedova, Inés DeLannoy, Edward M. Sellers - Frontiers in Pharmacology 2021 cited by 66

  6. Measurement issues in postpartum depression part 1: Anxiety as a feature of postpartum depression

    Authors: Lori E. Ross, Sandy Evans, Edward M. Sellers, Myroslava K. Romach - Archives of Women s Mental Health 2003 cited by 302

  7. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study

    Authors: C. Neill Epperson, Ralitza Gueorguieva, Kathryn A. Czarkowski, Stephanie Stiklus, Edward M. Sellers, John H. Krystal, Douglas L. Rothman, Graeme F. Mason - Psychopharmacology 2006 cited by 145

  8. Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers

    Authors: Laura E. Pope, M.H. Khalil, James E. Berg, Mark R. Stiles, Gerald J. Yakatan, Edward M. Sellers - The Journal of Clinical Pharmacology 2004 cited by 125

  9. Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*

    Authors: Viba Malaiyandi, Edward M. Sellers, Rachel F. Tyndale - Clinical Pharmacology & Therapeutics 2005 cited by 265

  10. Venlafaxine oxidationin vitrois catalysed by CYP2D6

    Authors: S V Otton, S. Ball, Siu Wah Cheung, T. Inaba, Richard L. Rudolph, Edward M. Sellers - British Journal of Clinical Pharmacology 1996 cited by 229

  11. Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence

    Authors: Edward M. Sellers, Tony Toneatto, Myroslava K. Romach, Gail Somer, Linda C. Sobell, Mark B. Sobell - Alcoholism Clinical and Experimental Research 1994 cited by 188

  12. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

    Authors: Edward M. Sellers - Clinical Pharmacology & Therapeutics 2000 cited by 180

  13. 3α-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period

    Authors: Susan Elizabeth Gilbert Evans, Lori E. Ross, Edward M. Sellers, Robert H. Purdy, Myroslava K. Romach - Gynecological Endocrinology 2005 cited by 112

  14. Nicotine physical dependence and tolerance in the mouse following chronic oral administration

    Authors: Sheri D. Grabus, Billy R. Martin, Angela M. Batman, Rachel F. Tyndale, Edward M. Sellers, M. Imad Damaj - Psychopharmacology 2004 cited by 98

  15. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

    Authors: Jill Mwenifumbo, Nael Al Koudsi, Man Ho, Qian Zhou, Ewa Hoffmann, Edward M. Sellers, Rachel F. Tyndale - Human Mutation 2008 cited by 85

  16. Paroxetine potentiates the central nervous system side effects of perphenazine: Contribution of cytochrome P4502D6 inhibition in vivo*

    Authors: Vural Özdemir, Claudio A. Naranjo, Nathan Herrmann, K. L. Reed, Edward M. Sellers, W. Kalow - Clinical Pharmacology & Therapeutics 1997 cited by 83

  17. A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

    Authors: Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang, Yuan Lü, Debra Kelsh, Bradley Vince, Edward M. Sellers - Journal of Psychopharmacology 2018 cited by 184

  18. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

    Authors: William Zhang, Tansel Kilicarslan, Rachel F. Tyndale, Edward M. Sellers - 2001 cited by 142

  19. Importance of Protein Binding for the Interpretation of Serum or Plasma Drug Concentrations

    Authors: David J. Greenblatt, Edward M. Sellers, Jan Koch‐Weser - The Journal of Clinical Pharmacology 1982 cited by 136

  20. CYP2A6 genetic variation and potential consequences

    Authors: Chun Xu, Shari D. Goodz, Edward M. Sellers, Rachel F. Tyndale - Advanced Drug Delivery Reviews 2002 cited by 133

  21. Methadone binding to orosomucoid (α1-acid glycoprotein): Determinant of free fraction in plasma

    Authors: Myroslava K. Romach, Kenneth M. Piafsky, James G. Abel, V Khouw, Edward M. Sellers - Clinical Pharmacology & Therapeutics 1981 cited by 118

  22. Pharmacokinetic Determinants of Drug Abuse and Dependence

    Authors: Usoa Busto, Edward M. Sellers - Clinical Pharmacokinetics 1986 cited by 88

  23. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.

    Authors: Edward M. Sellers, D H Zilm, N C Degani - Journal of Studies on Alcohol 1977 cited by 81

  24. Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study

    Authors: Darren Wilbraham, Paul H. Berg, Max Tsai, Emily Liffick, Li Shen Loo, Erin Doty, Edward M. Sellers - The Journal of Clinical Pharmacology 2019 cited by 29